Cargando…

The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses

Oncolytic viruses (OVs) are an emergent and unique therapy for cancer patients. Similar to chemo- and radiation therapy, OV can lyse (kill) cancer cell directly. In general, the advantages of OVs over other treatments are primarily: a higher safety profile (as shown by less adverse effects), ability...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelin, Adrian, Wang, Jiahu, Bell, John, Le Boeuf, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880516/
https://www.ncbi.nlm.nih.gov/pubmed/29637059
http://dx.doi.org/10.2147/OV.S137159
_version_ 1783311176093925376
author Pelin, Adrian
Wang, Jiahu
Bell, John
Le Boeuf, Fabrice
author_facet Pelin, Adrian
Wang, Jiahu
Bell, John
Le Boeuf, Fabrice
author_sort Pelin, Adrian
collection PubMed
description Oncolytic viruses (OVs) are an emergent and unique therapy for cancer patients. Similar to chemo- and radiation therapy, OV can lyse (kill) cancer cell directly. In general, the advantages of OVs over other treatments are primarily: a higher safety profile (as shown by less adverse effects), ability to replicate, transgene(s) delivery, and stimulation of a host’s immune system against cancer. The latter has prompted successful use of OVs with other immunotherapeutic strategies in a synergistic manner. In spite of extended testing in pre-clinical and clinical setting, using biologically derived therapeutics like virus always raises potential concerns about safety (replication at non-intended locations) and bio-availability of the product. Recent advent in in vivo imaging techniques dramatically improves the convenience of use, quality of pictures, and amount of information acquired. Easy assessing of safety/localization of the biotherapeutics like OVs became a new potential weapon in the physician’s arsenal to improve treatment outcome. Given that OVs are typically replicating, in vivo imaging can also track virus replication and persistence as well as precisely mapping tumor tissues presence. This review discusses the importance of imaging in vivo in evaluating OV efficacy, as well as currently available tools and techniques.
format Online
Article
Text
id pubmed-5880516
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58805162018-04-10 The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses Pelin, Adrian Wang, Jiahu Bell, John Le Boeuf, Fabrice Oncolytic Virother Review Oncolytic viruses (OVs) are an emergent and unique therapy for cancer patients. Similar to chemo- and radiation therapy, OV can lyse (kill) cancer cell directly. In general, the advantages of OVs over other treatments are primarily: a higher safety profile (as shown by less adverse effects), ability to replicate, transgene(s) delivery, and stimulation of a host’s immune system against cancer. The latter has prompted successful use of OVs with other immunotherapeutic strategies in a synergistic manner. In spite of extended testing in pre-clinical and clinical setting, using biologically derived therapeutics like virus always raises potential concerns about safety (replication at non-intended locations) and bio-availability of the product. Recent advent in in vivo imaging techniques dramatically improves the convenience of use, quality of pictures, and amount of information acquired. Easy assessing of safety/localization of the biotherapeutics like OVs became a new potential weapon in the physician’s arsenal to improve treatment outcome. Given that OVs are typically replicating, in vivo imaging can also track virus replication and persistence as well as precisely mapping tumor tissues presence. This review discusses the importance of imaging in vivo in evaluating OV efficacy, as well as currently available tools and techniques. Dove Medical Press 2018-03-28 /pmc/articles/PMC5880516/ /pubmed/29637059 http://dx.doi.org/10.2147/OV.S137159 Text en © 2018 Pelin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Pelin, Adrian
Wang, Jiahu
Bell, John
Le Boeuf, Fabrice
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title_full The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title_fullStr The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title_full_unstemmed The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title_short The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
title_sort importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880516/
https://www.ncbi.nlm.nih.gov/pubmed/29637059
http://dx.doi.org/10.2147/OV.S137159
work_keys_str_mv AT pelinadrian theimportanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT wangjiahu theimportanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT belljohn theimportanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT leboeuffabrice theimportanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT pelinadrian importanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT wangjiahu importanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT belljohn importanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses
AT leboeuffabrice importanceofimagingstrategiesforpreclinicalandclinicalinvivodistributionofoncolyticviruses